Table 3.
Categorization of Gingko biloba commercial unfinished products via different analyses
| Method of analysis | Characteristic GbE samples | Intermediate | Uncharacteristic GbE samples |
|---|---|---|---|
| HPLC-ELSD chromatographic visual inspection | 1, 1F, L, T, U1 | D, E, I, J, K, N, O, P, Q, R, S | A, B, C, F, G, H, M |
| HPLC-ELSD PCA | 1, 1F, U1 | D, E, I, J, K, L, M, N, O, P, Q, R, S, T | A, B, C, F, G, H |
| NMR qualitative/unsupervised | 1, 1A, 1F, I, J, K, L, N, O, Q, R, S, T, U1 | A, B, C, D, E, F, G, H, M, P | |
| HPTLC | 1A, L, T | D, E, G, I, J, K, N, O, P, Q, R, S | |
| HPLC analysis of GbE marker constituents | 1, 1A, 1F, L, T, U1 | D, E, I, J, K, N, O, Q, R, S | A, B, C, F, G, H, M, P |
| NMR quantification | 1, 1A, 1F, K, L, U1, T | D, E, I, J, N, O, Q, R, S | A, B, C, F G, H, M, P |
1NIST unfinished GbE SRM 3247